Hormone abuse, in sports: the antidoping perspective

被引:44
作者
Barroso, Osquel [1 ]
Mazzoni, Irene [1 ]
Rabin, Olivier [1 ]
机构
[1] WADA, Dept Sci, Montreal, PQ H4Z 1B7, Canada
关键词
World Anti-Doping Agency; doping; hormone; sport;
D O I
10.1111/j.1745-7262.2008.00402.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Since ancient times, unethical athletes have attempted to gain an unfair competitive advantage through the use of doping substances. A list of doping substances and methods banned in sports is published yearly by the World Anti-Doping Agency (WADA). A substance or method might be included in the List if it fulfills at least two of the following criteria: enhances sports performance; represents a risk to the athlete's health; or violates the spirit of sports. This list, constantly updated to reflect new developments in the pharmaceutical industry as well as doping trends, enumerates the drug types and methods prohibited in and out of competition. Among the substances included are steroidal and peptide hormones and their modulators, stimulants, glucocorticosteroids, beta 2-agonists, diuretics and masking agents, narcotics, and cannabinoids. Blood doping, tampering, infusions, and gene doping are examples of prohibited methods indicated on the List. From all these, hormones constitute by far the highest number of adverse analytical findings reported by antidoping laboratories. Although to date most are due to anabolic steroids, the advent of molecular biology techniques has made recombinant peptide hormones readily available. These substances are gradually changing the landscape of doping trends. Peptide hormones like erythropoietin (EPO), human growth hormone (hGH), insulin, and insulin-like growth factor I (IGF-I) are presumed to be widely abused for performance enhancement. Furthermore, as there is a paucity of techniques suitable for their detection, peptide hormones are all the more attractive to dishonest athletes. This article will overview the use of hormones as doping substances in sports, focusing mainly on peptide hormones as they represent a pressing challenge to the current fight against doping. Hormones and hormones modulators being developed by the pharmaceutical industry, which could emerge as new doping substances, are also discussed.
引用
收藏
页码:391 / 402
页数:12
相关论文
共 128 条
[1]   A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies [J].
Andersen, L ;
Jorgensen, PN ;
Jensen, LB ;
Walsh, D .
CLINICAL BIOCHEMISTRY, 2000, 33 (08) :627-633
[2]   GASepo -: a software solution for quantitative analysis of digital images in Epo doping control [J].
Bajla, I ;
Holländer, I ;
Minichmayr, M ;
Gmeiner, G ;
Reichel, C .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2005, 80 (03) :246-270
[3]   Insulin analogues [J].
Barnett, AH ;
Owens, DR .
LANCET, 1997, 349 (9044) :47-51
[4]  
BARRIENTOSPEREZ M, 2001, REV ENDOCRINOL NUTR, V9, P133
[5]   Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function [J].
Barton-Davis, ER ;
Shoturma, DI ;
Musaro, A ;
Rosenthal, N ;
Sweeney, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15603-15607
[6]   THE EFFECT OF CIRCULATING GROWTH HORMONE-BINDING PROTEIN ON METABOLIC-CLEARANCE, DISTRIBUTION, AND DEGRADATION OF HUMAN GROWTH-HORMONE [J].
BAUMANN, G ;
AMBURN, KD ;
BUCHANAN, TA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) :657-660
[7]   CARDIOVASCULAR EFFECTS OF PROLONGED GROWTH-HORMONE REPLACEMENT IN ADULTS [J].
BESHYAH, SA ;
SHAHI, M ;
FOALE, R ;
JOHNSTON, DG .
JOURNAL OF INTERNAL MEDICINE, 1995, 237 (01) :35-42
[8]   Test method: GH [J].
Bidlingmaier, M ;
Wu, ZD ;
Strasburger, CJ .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (01) :99-109
[9]   PREPARATION AND CHARACTERIZATION OF AN IMPROVED BETA-COOH-TERMINAL IMMUNOGEN FOR GENERATION OF SPECIFIC AND SENSITIVE ANTISERA TO HUMAN CHORIONIC-GONADOTROPIN [J].
BIRKEN, S ;
CANFIELD, R ;
AGOSTO, G ;
LEWIS, J .
ENDOCRINOLOGY, 1982, 110 (05) :1555-1563
[10]   Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites [J].
Birken, S ;
Berger, P ;
Bidart, JM ;
Weber, M ;
Bristow, A ;
Norman, RJ ;
Sturgeon, C ;
Stenman, UH .
CLINICAL CHEMISTRY, 2003, 49 (01) :144-154